Expression patterns and prognostic significances of RRM1 and ERCC1 in pancreatic carcinoma and cholangiocarcinoma

Expression patterns and prognostic significances of RRM1 and ERCC1 in pancreatic carcinoma and cholangiocarcinoma

Background: Aggressive pancreatobiliary tumors often require oxaliplatin-based therapies, instead of standard gemcitabine-based therapy and biomarker studies at diagnosis to decide the appropriate therapeutic regimen. The ribonucleotide Reductase catalytic subunit M1 (RRM1) and excision repair cross...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Khushbu Khetan, Ranjit K Sahoo, Vandana Baloda, Shalimar, Sreenivas Vishnubhatla, Anoop Saraya, Nihar Ranjan Dash, Atul Sharma, Siddhartha DattaGupta, Prasenjit Das
Formato: article
Lenguaje:EN
Publicado: Wolters Kluwer Medknow Publications 2021
Materias:
cholangiocarcinoma
excision repair cross-complementing gene-1
pancreatic adenocarcinoma
prognosis
ribonucleotide reductase catalytic subunit m1
Pathology
RB1-214
Microbiology
QR1-502
Acceso en línea:https://doaj.org/article/0308f19bce6a47979b52fb9fb0ccd539
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/0308f19bce6a47979b52fb9fb0ccd539

Ejemplares similares